they should not be directly compared with results from trials of other agents, as differences in trial design, population, background therapy, and follow-up duration make cross-trial comparisons unreliable
Knock-down of glutaminase 2 expression decreases glutathione, NADH, and sensitizes cervical cancer to ionizing radiation
Dysgeusia (a taste disorder)
Repeated flares not only degrade organ efficiency but also affect the energy and quality of digestion
Managing Sleep Disruption in Early GLP-1 Treatment Some individuals experience initial insomnia or frequent nighttime waking during the first few weeks on compounded semaglutide or tirzepatide, particularly if dosing escalates quickly
Giornale Italiano di Dermatologia e Venereologia (2020)